“omeros” Archives

Entry Author Date Location
Omeros Nabs $25M from Paul Allen, State Life Sciences Fund to Pursue Elusive Drug Targets 10/25/10 Seattle
Omeros Addiction Program Wins NIH Grant 10/14/10 Seattle
Omeros Lines Up $40M Financing 07/29/10 Seattle
Ironwood Climbs 3.6 Percent on IPO Debut Day, Shows Investor Interest—Albeit Tepid—in Biotech 02/03/10 Boston
Ironwood Pharma IPO Price Cut Could Be Only Half the Story 02/03/10 Boston
Ironwood Gears Up for Biotech’s Biggest IPO in Years, Sending Ripple Effect Through Industry 02/01/10 Boston
M&A Liquidity Up, IPO Market Still Anemic: Fourth-Quarter Data on Venture Exits Is a Mixed Bag 01/04/10 National
A Brief Year-End Review of Seattle Biotech 12/31/09 Seattle
Bezos Family Gives $10M to Hutch, Bruce Carter Back in the Saddle, Dendreon Deadline Set, & More Seattle-Area Life Sciences News 11/25/09 Seattle
Ironwood Files to Go Public, Seeks to Raise as Much as $172.5M 11/20/09 Boston
Omeros Banks on First FDA Filing Next Year, Plans to “Unlock” Inaccessible Drug Targets 11/19/09 Seattle
ZymoGenetics Rival Emerges, Omeros IPO Casts Shadow, Microsoft’s HealthVault Seeks Users, & More Seattle Area Life Sciences News 10/29/09 Seattle
Omeros, Worst Performing IPO of 2009, Casts Shadow Over Other Aspiring Biotechs 10/27/09 Seattle
Top 10 Northwest Venture Deals of the Third Quarter—and VC Color Commentary 10/20/09 Seattle
Dendreon Recruits Aces to Board, Amgen Seeks to Raise Hit Rate, Lee Hood Startup Gets $30M, & More Seattle-Area Life Sciences News 10/15/09 Seattle
Amazon Invests in Engine Yard, PopCap Raises $22.5M, Omeros Goes Public, & More Seattle-Area Deals News 10/14/09 Seattle
Omeros, First U.S. Biotech IPO Since February 2008, Sees Shares Drop 13 Percent in First Day 10/08/09 Seattle
Omeros Raises $68.2M in Washington’s First IPO in Two Years 10/08/09 Seattle
Omeros Accused on Eve of IPO, Seattle Genetics Trial Fails, How Much Biotechies Really Earn, & More Seattle-Area Life Sciences News 10/08/09 Seattle
Amazon Goes Mobile, Theraclone Inks $18M Deal, Spiration Pulls In $7M, & More Seattle-Area Deals News 10/06/09 Seattle
Omeros Made Errors on NIH Grant, But Feds Accepted Internal Investigation Saying They Weren’t Overbilled 10/05/09 Seattle
On Verge of Omeros IPO, Former Finance Chief Accuses Company of Filing False Records with NIH 10/02/09 Seattle
Omeros Teed Up for IPO Next Week, Seeking to Rake In More Than $80M 10/02/09 Seattle
The Seattle Biotech Survival Index: Companies Bounce Back in Mid-2009 09/22/09 Seattle
Free & Clear Acquired for $100M-Plus, Calypso Gets $50M, Ensequence Ensnares $20M, & More Seattle-Area Deals News 09/22/09 Seattle
Omeros Moves Closer to IPO, Zymo Drug Fails Arthritis Trials, Uptake Medical Gets $3.4M, & More Seattle-Area Life Sciences News 09/17/09 Seattle
Omeros Moves Closer To IPO, Sets Price Goal 09/16/09 Seattle
Omeros Gets Ready for IPO, Cray Buys SiCortex Assets, ClearEdge Raises Cash, & More Seattle-Area Deals News 09/01/09 Seattle
ZymoGenetics Plays Hardball, Targeted Genetics’ Legacy, Omeros Preps for Fall IPO, & More Seattle-Area Life Sciences News 08/27/09 Seattle
Omeros Plans to Test Waters with First Washington IPO in Two Years, Sources Say 08/26/09 Seattle
Page 2 of 3 « previous page · next page »